Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: the intriguing case of Mister B

J Endocrinol Invest. 2010 Mar;33(3):204-5. doi: 10.1007/BF03346583. Epub 2009 Jul 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenoma / drug therapy*
  • Adenoma / metabolism*
  • Delayed-Action Preparations / therapeutic use
  • Human Growth Hormone / analogs & derivatives
  • Human Growth Hormone / metabolism*
  • Human Growth Hormone / therapeutic use
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Octreotide / therapeutic use*
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / metabolism*
  • Thyrotropin / metabolism*

Substances

  • Delayed-Action Preparations
  • Human Growth Hormone
  • Thyrotropin
  • pegvisomant
  • Octreotide